News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
841,002 Results
Type
Article (86193)
Company Profile (649)
Press Release (754160)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232280)
Career Advice (4126)
Deals (39714)
Drug Delivery (126)
Drug Development (90831)
Employer Resources (198)
FDA (18024)
Job Trends (17335)
News (395701)
Policy (39685)
Tag
Academia (2993)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (84)
Alliances (56685)
ALS (87)
Alzheimer's disease (1481)
Antibody-drug conjugate (ADC) (150)
Approvals (18005)
Artificial intelligence (243)
Autoimmune disease (28)
Automation (14)
Bankruptcy (402)
Best Places to Work (12529)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (447)
Bladder cancer (78)
Brain cancer (26)
Breast cancer (251)
Cancer (2153)
Cardiovascular disease (155)
Career advice (3533)
Career pathing (34)
CAR-T (168)
Cell therapy (467)
Cervical cancer (19)
Clinical research (73057)
Collaboration (824)
Company closure (2)
Compensation (483)
Complete response letters (28)
COVID-19 (2836)
CRISPR (47)
C-suite (243)
Cystic fibrosis (101)
Data (2059)
Decentralized trials (2)
Denatured (46)
Depression (42)
Diabetes (207)
Diagnostics (6775)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (118)
Drug pricing (100)
Drug shortages (18)
Duchenne muscular dystrophy (97)
Earnings (95842)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (128923)
Executive appointments (681)
FDA (19157)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (696)
Gene editing (108)
Generative AI (23)
Gene therapy (336)
GLP-1 (755)
Government (5124)
Grass and pollen (4)
Guidances (122)
Healthcare (20746)
Huntington's disease (26)
IgA nephropathy (29)
Immunology and inflammation (138)
Indications (27)
Infectious disease (2957)
Inflammatory bowel disease (157)
Inflation Reduction Act (11)
Influenza (46)
Intellectual property (88)
Interviews (813)
IPO (17711)
IRA (38)
Job creations (5189)
Job search strategy (2861)
Kidney cancer (11)
Labor market (46)
Layoffs (556)
Leadership (22)
Legal (10058)
Liver cancer (75)
Lung cancer (302)
Lymphoma (147)
Machine learning (7)
Management (65)
Manufacturing (315)
MASH (81)
Medical device (14351)
Medtech (14356)
Mergers & acquisitions (22305)
Metabolic disorders (640)
Multiple sclerosis (82)
NASH (22)
Neurodegenerative disease (106)
Neuropsychiatric disorders (23)
Neuroscience (2023)
NextGen: Class of 2025 (7666)
Non-profit (5059)
Now hiring (41)
Obesity (337)
Opinion (273)
Ovarian cancer (75)
Pain (79)
Pancreatic cancer (71)
Parkinson's disease (147)
Partnered (20)
Patents (206)
Patient recruitment (107)
Peanut (48)
People (65042)
Pharmaceutical (132)
Pharmacy benefit managers (14)
Phase I (22567)
Phase II (31753)
Phase III (23893)
Pipeline (1239)
Policy (151)
Postmarket research (3542)
Preclinical (10173)
Press Release (72)
Prostate cancer (95)
Psychedelics (34)
Radiopharmaceuticals (253)
Rare diseases (376)
Real estate (7384)
Recruiting (75)
Regulatory (26544)
Reports (57)
Research institute (2648)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (35)
Schizophrenia (76)
Series A (130)
Series B (81)
Service/supplier (25)
Sickle cell disease (47)
Special edition (20)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4288)
State (2)
Stomach cancer (11)
Supply chain (53)
Tariffs (47)
The Weekly (83)
Vaccines (752)
Venture capitalists (42)
Weight loss (238)
Women's health (38)
Worklife (20)
Date
Today (159)
Last 7 days (841)
Last 30 days (2667)
Last 365 days (29110)
2025 (10226)
2024 (34454)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (55)
Alaska (7)
Arizona (248)
Arkansas (8)
Asia (49947)
Australia (8814)
California (5722)
Canada (1668)
China (526)
Colorado (192)
Connecticut (224)
Delaware (141)
Europe (114403)
Florida (737)
Georgia (157)
Hawaii (1)
Idaho (64)
Illinois (472)
India (26)
Indiana (281)
Iowa (10)
Japan (146)
Kansas (113)
Kentucky (17)
Louisiana (10)
Maine (59)
Maryland (872)
Massachusetts (4500)
Michigan (188)
Minnesota (333)
Mississippi (1)
Missouri (57)
Montana (24)
Nebraska (26)
Nevada (59)
New Hampshire (53)
New Jersey (1621)
New Mexico (27)
New York (1608)
North Carolina (1046)
North Dakota (8)
Northern California (2520)
Ohio (176)
Oklahoma (13)
Oregon (45)
Pennsylvania (1189)
Puerto Rico (13)
Rhode Island (24)
South America (1650)
South Carolina (6)
South Dakota (1)
Southern California (2140)
Tennessee (42)
Texas (769)
United States (21327)
Utah (128)
Virginia (108)
Washington D.C. (43)
Washington State (537)
West Virginia (2)
Wisconsin (47)
841,002 Results for "pivot bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pivot Bio Announces Appointment of Travis Frey as Chief Technology Officer
April 7, 2025
·
3 min read
Press Releases
Kincell Bio Welcomes Lawrence (Larry) Pitcher as Chief Operating Officer to Lead the Preparation for Pivotal and Commercial Supply of Cell Therapies for Clients
March 17, 2025
·
2 min read
Press Releases
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
·
4 min read
Press Releases
Pivot Bio Launches New Retail Distribution Partnerships
December 18, 2024
·
3 min read
Press Releases
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
May 7, 2025
·
4 min read
Press Releases
Pivot Bio Appoints Melih Keyman to Board of Directors
December 3, 2024
·
3 min read
Press Releases
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
March 17, 2025
·
6 min read
Press Releases
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
February 27, 2025
·
5 min read
Press Releases
Peer-Reviewed Study Validates Pivot Bio’s Gene-Edited Microbes as a Third Source of Nitrogen Delivery
January 19, 2025
·
5 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
1 of 84,101
Next
